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3-amino-propyltrimethoxysilane. We characterized the two-layer anticorrosive coating of Mg alloy AZ31 by
Fourier transform infrared spectroscopy, static contact angle measurement and optical profilometry,
potentiodynamic polarization and AC impedance measurements. Furthermore, heparin was covalently
conjugated onto the silane-treated AZ31 to render the coating haemocompatible, as demonstrated by reduced
platelet adhesion on the heparinized surface. The method reported here is also applicable to the preparation of
other types of biofunctional, anti-corrosive coatings and thus of significant interest in biodegradable implant
applications.
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Abstract  
Biodegradable magnesium (Mg) alloys are advantageous in various implant applications, as 
they reduce the risks associated with permanent metallic implants. However, the fast 
corrosion rate is usually a hindrance in biomedical applications. Here we report a facile two-
step procedure to introduce multifunctional, anticorrosive coatings on Mg alloys, such as 
AZ31. The first step involves treating the NaOH-activated Mg with bistriethoxysilylethane 
(BTSE) to immobilise a layer of densely crosslinked silane coating with good corrosion 
resistance; the second step is to impart amine functionality to the surface by treating the 
modified Mg with 3-amino-propyltrimethoxysilane (γ-APS). We characterised the two-layer 
anticorrosive coating of AZ31 Mg alloy by Fourier transform infrared spectroscopy, static 
contact angle measurement and optical profilometry, potentiodynamic polarization and AC 
impedance measurements. Furthermore, heparin was covalently conjugated onto the silane 
treated AZ31 to render the coating haemocompatible, as demonstrated by reduced platelet 
adhesion on the heparinised surface. The method reported here is also applicable to the 
preparation of other types of biofunctional, anticorrosive coatings, and thus of significant 
interest in biodegradable implant applications. 
 
Keywords: Magnesium alloy; heparin; silane; corrosion; biodegradable metallic implants; 
platelet adhesion  
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Introduction  
Metallic implants, such as stents, bone plates and artificial joints, are widely used in the 
human body. However, there are serious problems associated with permanent metallic 
implants, including restenosis, thrombosis, physical irritation, potential inflammatory 
responses and inability to adapt to the growth and changes of the human body [1]. In some 
cases, additional surgery is required to remove the implant after the tissue has sufficiently 
healed [2] and, as a consequence, researchers and clinicians are looking towards 
biodegradable implants that, once implanted, only remain for an appropriate period to “fix” 
the problem and then disappear [3]. Coupled with their strong mechanical properties and 
low cytotoxicity, magnesium (Mg) alloys have attracted increasing attention as candidate 
materials for biodegradable stents and bone plates [1, 4-6]. However, the potential clinical 
applications of Mg alloys have been hindered by their poor corrosion resistance. Fast 
corrosion of Mg alloys results in the generation of hydrogen bubbles and pH changes, which 
will damage surrounding tissues [7]. More seriously, fast corrosion can lead to early loss of 
mechanical stability of the Mg alloy implant before the end of the healing process [4]. 
Therefore, an appropriate corrosion rate becomes an essential requirement for the clinical 
applications of Mg alloys in biodegradable metallic implants. 
To improve the corrosion resistance of Mg alloys, several techniques have been employed, 
including development of new Mg alloys [8, 9], surface modification via nitrogen ion 
implantation [10, 11], anodizing [12], and the use of conversion coatings [13-15]. Among 
these technologies, silane based anticorrosive coatings of Mg alloys have been proven to be 
effective, economical and environmentally benign [16, 17]. Silanes are a group of silicon-
based organic-inorganic materials with the general formula R’(CH2)nSi(OR)3, where R’ is an 
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organofunctional group and R is a hydrolysable alkoxy group. When in contact with water, 
silanes hydrolyse to yield silanol groups (SiOH) that permit attachment to hydrated metal 
surfaces (Metal-OH) via the formation of Si-O-metal bonds [18]. In the meantime, the silanol 
groups undergo self-crosslinking via siloxane bonds (Si-O-Si), resulting in an organic 
protective layer chemically bound to the metallic substrates [19, 20].  
Bistriethoxysilylethane (BTSE) and 3-amino-propyltrimethoxysilane (γ-APS) are widely 
studied bis-silane and mono-silanes, respectively. Such silanes can provide functional 
moieties that enable further attachment of bioactive molecules to enhance the interfacial 
properties of metal implants with surrounding cells and tissue [21]. However, it is reported 
that the amino group of γ-APS preferentially bonds to metal surfaces, which results in 
defects in the silane coatings, thus allowing water to penetrate to the silane-metal interface 
[22, 23]. Compared to functional mono-silanes, non-functional “bis-silanes” provide better 
corrosion protection due to the formation of densely crosslinked 3D polysiloxane networks 
and stronger interfacial adhesion at various metal surfaces, including steel, Al alloy, Cu alloy, 
and Mg alloy [24]. To take advantage of both types of silanes, a two-step BTSE-γ-APS coating 
treatment has been developed by Van Ooij’s group to provide good corrosion protection for 
aluminium and steel [25]. However, to our knowledge, this two-step silane coating has not 
been applied to Mg alloys. 
Another key requirement for biodegradable metallic implants, especially for cardiovascular 
stents, is blood compatibility. Adhesion of platelets can induce thrombus formation and, 
consequently, implant failure [26]. Heparin remains the most frequently used anticoagulant 
reagent. Surface modification with heparin has been intensively explored for increasing the 
thromboresistance of biomedical implants. Previous studies demonstrated that heparin 
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coated stents reduced stent thrombosis [27, 28], and resulted in favourable event-free 
survival after 6 months [27].   
In this study, we developed a two-step BTSE-γ-APS coating strategy to produce a 
biofunctionalised anticorrosive coating on AZ31 Mg alloy. The silane layer was analysed 
using FTIR and optical profilometry; the anticorrosion properties of the coating was assessed 
by potentiodynamic polarization and AC impedance measurements. We also demonstrated 
that bioactive heparin can be covalently attached to the silane modified Mg alloy surface. 
Using this technology, we demonstrated both markedly improved corrosion resistance and 
blood compatibility of the resulting Mg alloy.  
Materials and Methods: 
Materials 
All reagents were used as received. Bistriethoxysilylethane (BTSE), 3-Amino-
propyltrimethoxysilane (γ-APS), N-hydroxysuccinimide (NHS), 1-ethyl-3-(3-
dimethylaminopropyl) carbodiimide (EDC), 2-morpholinoethanesulfonic acid (MES), heparin, 
phosphate buffered saline (PBS), toluidine blue O (TBO) and glutaraldehyde were from 
Sigma-Aldrich, Australia. AZ31 Mg alloy sheet with the nominal mass composition of 96% 
Mg, 3% Al and 1% Zn was purchased from Goodfellow Metals, UK. Simulated body fluid 
(SBF) solution was freshly prepared which contained 5.403 g NaCl, 0.504 g NaHCO3, 0.426 g 
Na2CO3, 0.225 g KCl, 0.230 g K2HPO4·3H2O, 0.311g MgCl2·6H2O, 0.8 g NaOH, 17.892 g HEPES, 
0.293 g CaCl2 and 0.072 g Na2SO4 in 1000 ml Milli-Q water. 
Silanization of AZ31 Mg alloy  
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The 2.0 mm thick AZ31 Mg alloy sheets were cut into 15 mm × 20 mm pieces and polished 
with progressively fine SiC papers up to grit 2000. The samples were ultrasonically cleaned 
using acetone, dried in air, and then immersed in a 3.0 M NaOH solution for 2 h to produce 
a uniform hydroxide layer on the substrates. The NaOH-activated Mg substrates are 
referred to as Mg-OH.  
BTSE or γ-APS solution was prepared by mixing 5 % silane, 90 % ethanol and 5 % MilliQ 
water. The solutions were stirred at room temperature (RT) for 1 h to allow the hydrolysis to 
proceed. AZ31 samples were then immersed in the hydrolysed BTSE solution at RT for 1 h, 
dried with hot air, and then cured at 120 ˚C for 1 h. For the second step coating, the BTSE 
treated samples, denoted as Mg-B, were soaked in the γ-APS solution at RT for 30 min 
before being cured at 120 ˚C for 1 h. The resultant samples were denoted as Mg-B-A. 
Surface modification of Mg-B-A with heparin 
EDC•HCl and NHS were added to a heparin solution (5.0 mg/ml) in MES buffer to a final 
concentration of 2.0 mg/ml. Mg-B-A samples were immersed in the above solution and 
shaken at RT for 4 h. The heparinised samples (Mg-B-A-Heparin) were rinsed 5 times in both 
PBS and then water, respectively.  
Physiochemical characterisation of the modified AZ31 samples 
The surface modified ZA31 samples were investigated using a SHIMADZU IRPrestige-21 
Fourier transform infrared spectrophotometer. Attenuated total reflection Fourier 
transform infrared (ATR-FTIR) spectra were recorded at a resolution of 4.0 cm-1 and a scan 
range of 2000 cm-1 to 700 cm-1. The surface morphology was analysed using a Veeco optical 
profiler NT9000 (Veeco Instruments Inc. USA). Static water contact angles were measured 
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using the sessile drop method (2.0 µL, Milli Q water) with a Dataphysics OCA20 Goniometer 
(DataPhysics Instruments GmbH, Germany).  
The amounts of surface accessible heparin were quantified using a TBO assay [29, 30]. In 
general, AZ31 samples were immersed in a freshly prepared TBO solution (0.04 wt% in 0.01 
M HCl/0.2 wt% NaCl solution, 2.0 ml per sample) and shaken gently at RT for 4 h followed by 
rinsing five times with MilliQ water. Then the AZ31 samples were soaked in ethanol/NaOH 
(4/1 v/v) solution for 10 min, and the released TBO was quantified by measuring the optical 
density of the solution at 530 nm. A standard curve was established using a series of 
standard solutions of heparin.  
Anticorrosion properties of modified AZ31 sample  
Potentiodynamic polarization curves were recorded at a scan rate of 5.0 mV/s in SBF using a 
CHI 660 system (CH Instruments, Inc. USA). Electrochemical impedance spectroscopy (EIS) 
measurements were carried out in SBF solution using a three electrode cell comprising of a 
1.0 cm2 modified AZ31 as the working electrode, a platinum mesh auxiliary electrode and 
Ag|AgCl (3.0 M NaCl) reference electrode. The samples were placed in electrolyte and the 
open circle potential monitored for 1h. Impedance spectroscopy was conducted between 
0.05 Hz and 100 kHz at the measured open-circuit potential with an AC amplitude of 10 mV 
using a Gamry Potentiostatic PCI 750 system (Gamry Instruments, USA). The long term 
immersion experiments were performed at 37℃, the samples were then removed and the 
electrochemical measurement performed at room temperature (24℃). 
Platelet adhesion analysis 
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Fresh whole rat blood, with EDTA as anticoagulant was obtained from Australia Animal 
Resources Centre. The blood samples were centrifuged at 300×g for 10 minutes at RT to 
isolate platelet rich plasma (PRP). After removal of the PRP, the remaining samples were 
centrifuged at 2500xg for 10 min at RT to isolate platelet pool plasma (PPP). The number of 
platelets in the PRP was diluted to 1×108 cells/ml by mixing PRP with PPP. Modified AZ31 
samples were immersed into PRP for 1 h at 37˚C. Thereafter, the samples were rinsed twice 
with PBS, fixed with 2% glutaraldehyde for 2 h, dehydrated in a series of increasing 
concentrations of ethanol to 100 per cent, and then observed using a JEOL 7500FA FESEM.  
Statistical analysis 
All data are expressed as mean ± SD, unless specified; an unpaired student’s t-test was used 
for comparison, and a p-value of less than 0.05 was considered to be statistically significant.  
Results and discussion: 
Surface modification of AZ31 Mg alloy 
The surface modification scheme for AZ31 Mg alloy is shown in Figure 1. To facilitate silane 
coating, AZ31 Mg alloy was pre-treated with NaOH to generate surface hydroxide groups 
(Mg-OH); BTSE and γ-APS were hydrolysed to yield silanol groups. Mg-OH was then 
sequentially treated with the hydrolysed BTSE and γ-APS to introduce a two-layer silane 
coating through oxane bond formation with elimination of water. These processes are 
accompanied by in situ polycondensation of the hydrolysed BSTE and γ-APS to form the 
polysiloxane networks with surface amine functionality. In this study, heparin was employed 
as an example of bioactive molecules, and conjugated onto the aminized silane coating of 
AZ31 Mg alloy to improve the substrate’s blood compatibility.  
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FTIR spectrum (Figure 2) clearly show peaks around 1045-1127 cm-1 that correspond to the 
Si-O asymmetric stretching in -Si-O-Si- [19, 25]. Subsequent coating with γ-APS significantly 
increases the intensities of these peaks, with the appearance of a new peak around 1570 
cm-1 that is assigned to the protonated amino groups [25].  Our FTIR results are consistent 
with those reported for BTSE and/or γ-APS treated Al, Fe and Mg samples [17, 19, 25, 31]. 
 
Physiochemical properties of the surface modified AZ31 Mg alloys 
The influence of modification on the surface morphology of the Mg alloys was investigated 
(Figure 3). Bare AZ31 sample showed a uniformly patterned morphology associated with the 
polishing procedure, with surface roughness (Ra) of 148.7±16.5 nm (Table 1). Mg-OH still 
retained the polishing-induced regular pattern, but with increased Ra of 203.1±6.5 nm. A 
much rougher surface morphology (Ra ≈ 910.3±2.2) was noted for Mg-B, attributable to the 
BTSE coating. The subsequent modification with γ-APS markedly reduced the Ra of Mg-B-A 
to 761.7±51.2 nm, and this is presumably due to the existence of the grafted γ-APS as an 
overlayer on the modified AZ31 surface. Further conjugation of heparin onto Mg-B-A 
resulted in the roughest surface morphology amongst the tested samples, with a Ra of 
2320±57.7 nm. During the two-step silane coating and heparin modification, the polishing-
induced regular pattern that is evident on bare AZ31 becomes less distinctive.  
 
The influence of modification is also reflected in the changes in surface wettability of the 
modified AZ31 alloys, as characterised by static contact angle measurement (Figure 4). Bare 
AZ31 exhibits surface hydrophobicity, with a contact angle of 75.2±2.0˚. The pre-treatment 
with NaOH increased the surface hydrophilicity of Mg-OH, giving a water contact angle of 
14.4±1.9˚. As expected, incorporation of the BTSE layer re-established the surface 
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hydrophobicity, with the static contact angle increasing to 103.2±1.8˚. Compared to Mg-B, 
Mg-B-A is less hydrophobic with a lower contact angle of 78.2±1.5˚, ascribed to the 
presence of surface amine moieties. Further modification with heparin rendered the surface 
hydrophilic [32], as characterised by  a much lower water contact angle of 21.4±2.2˚.  
 
Corrosion resistance properties of the modified AZ31 Mg alloys 
Functional silanes, such as γ-APS, have often been used for modification of stainless steel 
[33] and Ti [30, 34] to provide surface functionality for post chemical anchorage of 
biomolecules (e.g. collagen, heparin and fibronectin), with a view to improving the 
biocompatibility of these metallic implants. However, functional silanes, such as γ-APS, have 
failed to provide effective corrosion resistance for metals and their alloys [24]. As reported 
by others [24, 25], there are two regions within a silane coating which can provide corrosion 
resistance: the crosslinked outer silane layer enriched with Si-O-Si bonds and the interfacial 
layer dominated by Si-O-metal bonds. The more hydrophobic the outer layer, the lower the 
water penetration rate [25]. As a bis-silane such as BTSE is more hydrophobic than γ-APS, 
and the interfacial regions between bis-silane and metal contains a higher density of Si-O-
metal bonds than that of a mono-silane, BTSE provides better corrosion protection than γ-
APS at both the outer layer and the interfacial layer.  Silanes have been widely used as 
coupling agents in clinical applications for more than 50 years, particularly in dentistry as 
adhesion promoters [35]. They have proven to be safe in vivo [35, 36]. However, the 
applications of silane coatings in dentistry are limited by bond degradation [35] associated 
with the hydrolytic cleaving of the siloxane bonds. In this works for degradable implant 
applications, the purpose of the silane coatings is to slow down the initial corrosion rate 
rather than totally stop the corrosion process. Therefore bond degradation is expected 
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when water penetrates to the interface between the silane coating and the Mg substrate 
resulting in detachment of the silane coating. Previous studies have shown that stents will 
be encapsulated by neointimal tissue after implantation [37], therefore as long as 
detachment occurs after the neointimal formation, silane coating fragments may be 
retained and localised rather than being lost into the bloodstream. So the risk associate with 
silane coating detachment can be controlled by the development of novel silane coupling 
agents with increased bond strength and hydrolytic stability. The two-step coating 
procedure reported here aims to combine the advantages of both BTSE and γ-APS to 
produce anticorrosive coatings with surface functionality. The chemically bound BTSE layer 
introduced in the 1st step coating serves as a hydrophobic barrier, improving the hydrolytic 
stability of the silane coating and preventing the underlying Mg from rapid corrosion. This is 
clearly demonstrated in the corrosion resistance study (Figure 5 and Figure 6) of the 
modified Mg alloys. 
 
Polarization curves of the modified AZ31 Mg alloys are shown in Figure 5 and the corrosion 
current (Icorr) values are summarised in Table 1. Compared to bare Mg, the Icorr value 
decreased by ~68% for Mg-B, and ~89% for Mg-B-A. As Icorr is directly proportional to the 
corrosion rate [38], a distinct improvement in corrosion resistance is indicated. The 
corrosion of magnesium involves reaction of H2O with Mg to produce Mg(OH)2 and H2. The 
overall reaction includes an anodic (Mg→Mg2++2e-) and cathodic reaction (2H2O+2e-
→H2+2OH-) [39]. After NaOH passivation, AZ31 surfaces were covered by a layer of Mg(OH)2 
film. The metal cation transport dominates the anodic kinetics as the anodic Mg dissolution 
reaction occurs on the AZ31 surface underlying the Mg(OH)2 film.  The Mg(OH)2 film cannot 
stop electrolyte penetration as it is porous and unstable in the aqueous environment. The 
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charge transfer associated with the cathodic reaction can occur, both beneath and on top of 
the film, which results in a higher cathodic current density compared to silane coated 
samples. After BTSE coating, the exchange current density from the cathodic reaction is 
reduced because the hydrophobic silane film acts as a physical barrier to retard water 
penetration and electron transport. The anodic dissolution reactions rates were also slowed 
as the silane coating blocks mass transport of Mg2+ [24]. At the same time, the formation of 
Si-O-Mg bonds at the interface also blocks some anodic reactions [24, 31]. The second layer 
of  γ-APS coating reduces the electrolyte penetration and electron transport process which 
further reduces the corrosion current by around one order of magnitude as compared to 
uncoated AZ31 samples. The shift of corrosion potential towards the cathodic direction also 
indicates that the hydrophobic silane film acts as a physical barrier to retard the electrolyte 
penetration [31]. Further modification of Mg-B-A with heparin resulted in an increase in Icorr 
from 0.9 µA to 1.87 µA, which may be due to the outer layer silane film being saturated with 
the electrolyte during the covalent conjugation process and thus partly losing its function as 
a physical barrier to retard the electrolyte penetration [24]. However, even in this case, the 
Icorr of Mg-B-A-Heparin is still lower than that of bare AZ31.  
The anticorrosive properties of modified AZ31 samples were also assessed by 
electrochemical impedance spectroscopy (EIS) (Figure 6). In the whole frequency range 
examined, applying the BTSE coating and BTSE-γ-APS coating resulted in a progressive 
increase in impedance. Compared to bare AZ31, the impedance of Mg-B-A increased by one 
order of magnitude as a result of the non-conductive silane coating, which indicates 
effective protection of the metal surface [24]. Similar to the Icorr result, the impedance of 
Mg-B-A-heparin sample is reduced to a similar level as that of Mg-B, but is still 4 times 
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higher than that of the untreated AZ31 sample. EIS spectra of Mg and Mg-A-B-heparin 
samples were also recorded in SBF at 37℃ every 6 h over a 42 h period (Figure 7). Two 
capacitive semicircles are clearly observed over the first hour for the uncoated AZ31 and 
silane coated samples. For uncoated AZ31 samples, the middle frequency (mf) semicircles 
disappeared and a low frequency (lf) inductive loop appears after 6 h immersion indicating 
severe pitting corrosion [40].  For silane coated samples (Mg-B-A-heparin), both semicircles 
are clearly evident up to 24h immersion, after which time both semicircles appear to merge 
into one large semicircle with an associated increase in impedance suggesting improved 
corrosion protection [17, 41]. 
Platelet adhesion behaviour on the modified AZ31 Mg alloys 
Compared to the single functional silane coating approach reported previously [16, 17, 42], 
this work utilizes BTSE as the first layer of coating to provide a hydrophobic barrier while 
minimising the interference from the functional groups (e.g. amino group [23]), which is 
important for the improved corrosion resistance of modified AZ31. In addition, the unique 
two-step coating offers potential for further modification to improve the biocompatibility of 
Mg alloy implants. In this work, heparin has been covalently conjugated onto the modified 
Mg surface via the amino groups provided by the grafted γ-APS. The density of surface 
accessible heparin, as determined by the TBO assay, is ∼12 µg/cm2 (Figure 8), which is 
significantly higher than that of the blank control. This value is comparable to those of 
heparin modified surfaces that were shown to effectively improve blood compatibility [30, 
43]. To assess whether the heparin retained bioactivity after covalent conjugation, platelet 
adhesion assays were performed across different samples. In contrast to the silane modified 
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AZ31 samples, significantly lower platelet adhesion was observed on the Mg-B-A-heparin 
surface (Figure 9).  
Conclusions 
Through the route of a two-step coating process, we have developed biofunctionalised, 
anticorrosive silane coatings for biodegradable Mg alloys. Compared to bare AZ31 Mg alloy, 
Mg-B-A-Heparin exhibits both an improved corrosion resistance and reduced platelet 
adhesion. The development of a surface modification strategy that can simultaneously 
control the Mg alloy corrosion resistance and inhibit platelet adhesion will inevitably have 
major significance for improving the blood compatibility of biodegradable metallic implants.  
In addition, this work opens up new avenues and a potential platform to functionalise Mg 
alloys based on chemical anchorage and in situ condensation of two types of silanes, a 
process which then provides functional groups for the further immobilization of essential 
biological components to facilitate the ongoing development of biodegradable metallic 
implants. 
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Figure 1. A: Hydrolysis process of BTSE; B: Hydrolysis process of  γ-APS, and C: Schematic 
illustration of the surface modification procedure of AZ31Mg alloy. 
Figure  2. FTIR spectra of Mg, Mg-OH, Mg-B and Mg-B-A. 
Figure 3. Surface morphologies of AZ31 samples with different treatment: fresh polished Mg 
(A), Mg-OH (B), Mg-B (C), Mg-B-A (D) and Mg-B-A-heparin (E). 
Figure 4. Static water contact angles of Mg, Mg-OH, Mg-B, Mg-B-A and Mg-B-A-Heparin 
samples.  
Figure 5. Polarization curves of Mg, Mg-OH, Mg-B, Mg-B-A and Mg-B-A-Heparin samples.  
Figure 6. Impedance spectra of Mg, Mg-OH, Mg-B, Mg-B-A and Mg-B-A-heparin samples.   
Figure 7.Impedance spectra of Mg and Mg-B-A-heparin samples in SBF solution at 1, 6, 12, 
18, 24, 30, 36 and 42h.   
Figure 8. Quantitative characterisation of the surface accessible heparins on Mg-B-A and 
Mg-B-A-Heparin samples.  
Figure 9. Representative SEM micrographs of platelets on Mg-B-A (A) and Mg-B-A-heparin 
(B). The scale bars represent 2 µm. 
 
Table 1: Contact angle, surface roughness (Ra), corrosion current (Icorr) and corrosion 
resistance (Rp) values of Mg alloy samples after different treatments. The sample size (n) for 
roughness and contact angle measurements is 5 and 3 for Icorr and Rp. 
AZ31 Samples Abbr*. Ra (nm) Contact angle (˚) 
Icorr 
(µA/cm2) Rp ( ohms/ cm
2) 
As polished Mg 148.7 ±16.5 75.2 ±2.0 8.32±0.63 2650±538 
NaOH passivated Mg-OH 203.1 ±6.5 14.4 ±1.9 5.10±1.42 3178±787 
BTSE coated Mg-B 910.3 ±2.2 103.2 ±1.8   2.69±0.31 7788±2572 
BTSE+APS coated Mg-B-A 761.7 ±51.2 78.2 ±1.5 0.90±0.24 13635±2745 
BTSE+APS+heparin 
coated 
Mg-B-A-
heparin 2320 ±57.7 21.4 ±2.2 1.87±0.23 9515±497 
*Abbr = abbreviation 
Table 1: Contact angle, surface roughness (Ra), corrosion current (Icorr) and corrosion 
resistance (Rp) values of Mg alloy samples after different treatments. The sample size (n) for 
roughness and contact angle measurements is 5 and 3 for Icorr and Rp. 
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